USPTO serial 79224188
OSLER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- TRUSILO, KELLY JEAN
- Law office
- TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with OSLER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Eric Lamb
Eric Lamb Frost Brown Todd LLP111 Monument Circle, Suite 4500Indianapolis, IN 46204United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Assays and reagents for scientific or medical research purposes | ACTIVE | — |
| 005 | Pharmaceutical preparations for the treatment of autoimmune diseases, allergies and asthma, cancer, Celiac disease, Crohn's and colitis, heart disease, infectious diseases, liver disease, Lupus, Multiple Sclerosis, Relapsing Polychondritis, Rheumatoid Arthritis, Scleroderma, and Diabetes; medical preparations, namely, medicines for the treatment of autoimmune diseases, allergies and asthma, cancer, Celiac disease, Crohn's and colitis, heart disease, infectious diseases, liver disease, Lupus, Multiple Sclerosis, Relapsing Polychondritis, Rheumatoid Arthritis, Scleroderma, and Diabetes; chemical preparations and reagents for medical purposes for the treatment of autoimmune diseases, allergies and asthma, cancer, Celiac disease, Crohn's and colitis, heart disease, infectious diseases, liver disease, Lupus, Multiple Sclerosis, Relapsing Polychondritis, Rheumatoid Arthritis, Scleroderma, and Diabetes; diagnostic preparations, substances, agents, reagents, and assays for medical purposes; diagnostic testing preparations, substances, agents, reagents, and assays for medical purposes | ACTIVE | — |
| 009 | Scientific apparatus and instruments, namely, devices for taking and testing blood samples; scientific research and laboratory apparatus and instruments, namely, devices for taking and testing blood samples; material testing apparatus and instruments, namely, devices for taking and testing blood samples; monitoring, measuring, signalling and control apparatus and instruments, namely, devices for taking and testing blood samples; audio-visual apparatus and instruments, namely, screens and devices for displaying diagnostic test results; computer apparatus and instruments, namely, screens and devices for taking and displaying diagnostic test results; software for processing diagnostic test results; application software for taking and displaying diagnostic test results in the field of diagnosing and treating diseases and conditions; data capture, collection, recording, processing, transmission, reproduction, storage and/or communications apparatus and instruments, namely, screens and devices for taking and displaying diagnostic test results; electrical and electronic components, namely, screens and devices for taking and displaying diagnostic test results; structural parts and fittings for all the aforementioned goods | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, injection and drawing devices for diagnostic testing; medical diagnostic apparatus and instruments, namely, injection and drawing devices; testing apparatus and instruments for medical and/or medical diagnostic purposes, namely, injection and drawing devices; diagnostic testing apparatus and instruments for the measurement of clinical bio markers; structural parts and fittings for all the aforementioned goods | ACTIVE | — |
| 025 | Clothing, namely, shirts, pants, hats, socks; footwear; headwear | ACTIVE | — |
| 041 | Education, namely, seminars and classes about patient health and wellbeing, training in the field of patient health and wellbeing and research in the field of education; publishing services of books, guides, workbooks, manuals, brochures; publication of medical and/or scientific publications; consultancy, advisory and/or information services relating to or connected with the aforementioned services | ACTIVE | — |
| 042 | Research and development services in the field of human conditions and diseases; medical research and development services; scientific research and development services; pharmaceutical research and development services; design services in the field of medical and health screening and assessment; research, design and development of medical apparatus and instruments; research, design and development of medical diagnostic apparatus and instruments; research, design and development of diagnostic tests for the measurement of clinical bio markers; software research, design and development services; consultancy, advisory and/or information services relating to or connected with the aforementioned services | ACTIVE | — |
| 044 | Medical services; medical diagnostic services; medical testing, screening and analysis services relating to the diagnosis and/or treatment of disease; consultancy, advisory and/or information services relating to or connected with the aforementioned services | ACTIVE | — |
| 045 | Intellectual property licensing services; licensing of technology; licensing of manufacturing technology and/or manufacturing processes; licensing of intellectual property and/or intellectual property rights; licensing of industrial property and/or industrial property rights; licensing of patents, confidential information, technical information and/or know-how; consultancy, advisory and/or information services relating to or connected with the aforementioned services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Osler Diagnostics Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 025
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named OSLER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 8, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 8, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 8, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 8, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 8, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 2, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 24, 2020 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 3, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 3, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 26, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 5, 2019 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 21, 2019 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 5, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 5, 2019 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 3, 2019 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 3, 2019 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 5, 2018 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 5, 2018 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 5, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 9, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 9, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 9, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 9, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 2, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 9, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 9, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 7, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 6, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 5, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 12, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 8, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 4, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |